Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Calithera Biosciences, Inc. has filed 530 SEC EDGAR filings since 16 Jul 2010

SEC filing history

Showing 351-375 of 530 matching filings.

Per page
25
Current page
15
8-K File 001-36644

FORM 8-K

Filing date
09 May 2017
Reporting date
09 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36644

DEFINITIVE ADDITIONAL MATERIALS

Filing date
21 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36644

DEFINITIVE PROXY STATEMENT

Filing date
21 Apr 2017
Reporting date
09 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

CALITHERA BIOSCIENCES, INC.

Filing date
24 Mar 2017
Reporting date
22 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36644

8-K

Filing date
22 Mar 2017
Reporting date
21 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-207905

FILED PURSUANT TO RULE 424(B)(5)

Filing date
22 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-207905

FILED PURSUANT TO RULE 424(B)(5)

Filing date
20 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-216740

S-8

Filing date
16 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36644

FORM 8-K

Filing date
16 Mar 2017
Reporting date
16 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Mar 2017
Reporting date
13 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36644

FORM 8-K

Filing date
13 Mar 2017
Reporting date
07 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88349

SEC SCHEDULE 13G

Filing date
10 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Mar 2017
Reporting date
02 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88349

SEC SCHEDULE 13G

Filing date
06 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88349

SC 13G filing

Filing date
21 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88349

SC 13D/A

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88349

CALITHERA BIOSCIENCES, INC.

Filing date
09 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88349

SC 13G

Filing date
31 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36644

FORM 8-K

Filing date
30 Jan 2017
Reporting date
27 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-207905

FILED PURSUANT TO RULE 424(B)(5)

Filing date
30 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Jan 2017
Reporting date
01 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Jan 2017
Reporting date
01 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Dec 2016
Reporting date
19 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .